England’s biotech startup Sitryx out of the blocks with new I/O program. Stakes are high as Europe’s science contending with US for top global developers.
The News: Sitryx Therapeutics Ltd. (London) has launched with the goal of treating cancer and inflammatory conditions by targeting the metabolism of immune cells, a promising new area of research…. Read more »